Overexpression of G9a and MCM7 in oesophageal squamous cell carcinoma is associated with poor prognosis

Histopathology

Volumn 66, Issue 2, 2015, Pages 192-200

  Zhong, Xinwen ^a   Chen, Xiaolong ^a   Guan, Xiaojiao ^a   Zhang, Heng ^a   Ma, Yinan ^a   Zhang, Shuguang ^a   Wang, Enhua ^a   Zhang, Lin ^a   Han, Yuchen ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

G9a; MCM7; Oesophageal squamous cell carcinoma; Prognosis

Indexed keywords

FORMALDEHYDE; HISTONE METHYLTRANSFERASE; HISTONE METHYLTRANSFERASE G9A; MINICHROMOSOME MAINTENANCE PROTEIN 7; PARAFFIN; UNCLASSIFIED DRUG; EHMT2 PROTEIN, HUMAN; HISTOCOMPATIBILITY ANTIGEN; HISTONE LYSINE METHYLTRANSFERASE; MCM7 PROTEIN, HUMAN; SMALL INTERFERING RNA; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISTANT METASTASIS; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; FOLLOW UP; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; TISSUE MICROARRAY; UPREGULATION; BIOSYNTHESIS; ESOPHAGUS TUMOR; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; SQUAMOUS CELL CARCINOMA; VERY ELDERLY; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; HISTOCOMPATIBILITY ANTIGENS; HISTONE-LYSINE N-METHYLTRANSFERASE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MINICHROMOSOME MAINTENANCE COMPLEX COMPONENT 7; PROGNOSIS; RNA, SMALL INTERFERING; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84925259862     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/his.12456     Document Type: Article

References (24)

1. Kato H, Fukuchi M, Miyazaki T et al. Surgical treatment for esopharyngeal cancer. Current issues. Dig. Surg. 2007; 24; 88-95.
2. Purcell DJ, Jeong KW, Bittencourt D, Gerke DS, Stallcup MR. A distinct mechanism for coactivator versus corepressor function by histone methyltransferase G9a in transcriptional regulation. J. Biol. Chem. 2011; 286; 41963-41971.
3. Tachibana M, Ueda J, Fukuda M et al. Histone methyltransferases G9a and GLP form heteromeric complexes and are both crucial for methylation of euchromatin at H3-K9. Genes Dev. 2005; 19; 815-826.
4. Yokochi T, Poduch K, Ryba T et al. G9a selectively represses a class of late-replicating genes at the nuclear periphery. Proc. Natl Acad. Sci. USA 2009; 106; 19363-19368.
5. Ueda J, Makoto M, Ikura T, Shinkai Y. Zinc finger protein wiz links G9a/GLP histone methyltransferases to the corepressor molecule CtBP. J. Biol. Chem. 2006; 281; 20120- 20128.
6. Lee DY, Northrop JP, Kuo M-H, Stallcup MR. Histone H3 lysine 9 methyltransferase G9a is a transcriptional coactivator for nuclear receptors. J. Biol. Chem. 2006; 281; 8476-8485.
7. Duan Z, Zarebski A, Montoya-Durango D, Grimes HL, Horwitz M. Gfi1 coordinates epigenetic repression of p21Cip/ WAF1 by recruitment of histone lysine methyltransferase G9a and histone deacetylase 1. Mol. Cell. Biol. 2005; 25; 10338-10351.
8. Cho HS, Kelly JD, Hayami S et al. Enhanced expression of EHMT2 is involved in the proliferation of cancer cells through negative regulation of SIAH1. Neoplasia 2011; 13; 676-684.
9. Luo JH. Oncogenic activity of MCM7 transforming cluster. World J. Clin. Oncol. 2011; 2; 120-124.
10. Labib K, Tercero JA, Diffley JF. Uninterrupted MCM2-7 function required for DNA replication fork progression. Science 2000; 288; 1643-1647.
11. Slaymaker IM, Fu Y, Toso DB et al. Mini-chromosome maintenance complexes form a filament to remodel DNA structure and topology. Nucleic Acids Res. 2013; 41; 3446-3456.
12. Li F, Martienssen R, Cande WZ. Coordination of DNA replication and histone modification by the Rik1-Dos2 complex. Nature 2011; 475; 244-249.
13. Huang TH, Huo L, Wang YN et al. Epidermal growth factor receptor potentiates MCM7-mediated DNA replication through tyrosine phosphorylation of Lyn kinase in human cancers. Cancer Cell 2013; 23; 796-810.
14. Wei Q, Li J, Liu T, Tong X, Ye X. Phosphorylation of minichromosome maintenance protein 7 (MCM7) by cyclin/cyclindependent kinase affects its function in cell cycle regulation. J. Biol. Chem. 2013; 288; 19715-19725.
15. Kondo Y, Shen L, Ahmed S et al. Downregulation of histone H3 lysine 9 methyltransferase G9a induces centrosome disruption and chromosome instability in cancer cells. PLoS One 2008; 3; 2037.
16. Gyory I, Wu J, Fejer G, Seto E, Wright KL. PRDI-BF1 recruits the histone H3 methyltransferase G9a in transcriptional silencing. Nat. Immunol. 2004; 5; 299-308.
17. Wu H, Zhang H, Wang P et al. Short-form CDYLb but not long-form CDYLa functions cooperatively with histone methyltransferase G9a in hepatocellular carcinomas. Genes Chromosom. Cancer 2013; 52; 644-655.
18. Purcell DJ, Khalid O, Ou CY et al. Recruitment of coregulator G9a by Runx2 for selective enhancement or suppression of transcription. J. Cell. Biochem. 2012; 113; 2406-2414. doi:10. 1002/jcb.24114.
19. Chen MW, Hua KT, Kao HJ et al. H3K9 histone methyltransferase G9a promotes lung cancer invasion and metastasis by silencing the cell adhesion molecule Ep-CAM. Cancer Res. 2010; 70; 7830-7840.
20. Dong C, Wu Y, Yao J et al. G9a interacts with Snail and is critical for Snail-mediated E-cadherin repression in human breast cancer. J. Clin. Invest. 2012; 122; 1469-1486.
21. Lei M, Tye BK. Initiating DNA synthesis: from recruiting to activating the MCM complex. J. Cell Sci. 2001; 114; 1447- 1454.
22. Kikuchi J, Kinoshita I, Shimizu Y et al. Minichromosome maintenance (MCM) protein 4 as a marker for proliferation and its clinical and clinicopathological significance in non-small cell lung cancer. Lung Cancer 2011; 72; 229-237.
23. Lau KM, Chan QK, Pang JC et al. Minichromosome maintenance proteins 2, 3 and 7 in medulloblastoma: overexpression and involvement in regulation of cell migration and invasion. Oncogene 2010; 29; 5475-5489.
24. Ramnath N, Hernandez FJ, Tan DF et al. MCM2 is an independent predictor of survival in patients with non-small-cell lung cancer. J. Clin. Oncol. 2001; 19; 4259-4266.